Fri, 23 Jun|
Hotel Murtenhof & Krone
11th Swiss MD-PhD Conference
Annual conference of the SMPA, focusing this year on "Novel approaches to unresolved challenges". Join us for exciting talks and workshops, stimulating discussions and unique networking opportunities. Open to all MDs and medical students interested in science.
Time & Location
23 Jun, 09:30 – 24 Jun, 16:00
Hotel Murtenhof & Krone, Rathausgasse 3, 3280 Murten, Switzerland
About the event
We are happy to offer participation at the Conference at no cost to our members. Non-members are required to pay a non-refundable registration fee of CHF 60. To profit from the membership discount, apply for membership and pay the annual fee (CHF 30 for extraordinary members, CHF 50 for ordinary members) by following the link below. You will be able to register for free immediately upon completing the payment. In case of questions and issues, do not hesitate to contact us at firstname.lastname@example.org.
Please note that your registration includes an overnight stay in the Hotel Murtenhof & Krone (incl. food and beverages) at no additional costs (apart from the registration fee). However, due to numerous last-minute cancellations in the previous years, we are forced to implement a strict cancelation policy to avoid financial loss as follows:
The registration fee (CHF 60) will not be refunded, regardless of the time of cancellation.
In addition, the following applies with regard to the cost of accommodation:
1. Cancelation until 02 May 2023: No additional fees.
2. Cancelation between 02 May and 02 June 2023: The participant must cover 50% of the accommodation costs (CHF 145).
3. Cancelation after 02 June 2023: The participant must cover 100% of the accommodation costs (CHF 290).
IMPORTANT: The ticket includes an overnight stay in the Hotel Murtenhof & Krone (incl. food and beverages). Please pay attention to the cancelation policy. The registration fee will not be refunded. In addition, in case of late cancelations, the participant must cover up to 100% of the accommodation costs, as detailed above.
MEET THE KEYNOTE SPEAKERS
CEO Speransa Therapeutics
Topic: “From research to the vaccine vials”
Madiha has been working on vector engineering and vaccine design for over 17 years. She has a strong background in applied molecular and cellular biotechnology, in virology and in immunology, with research interests at the interface of fundamental and translational research, the so-called bench-to-bedside. She especially focuses on immune stimulation and immune modulation, both in the oncology and infectious disease fields.
Madiha holds a PhD in Biotechnology from the Ecole Polytechnique Fédérale de Lausanne (EPFL), Switzerland and a Master in Biotechnology Engineering from the University of Technology of Berlin, Germany.
Madiha is also the Scientific Founder of AMAL Therapeutics, a Swiss biotech company developing first-in-class therapeutic cancer vaccines. She designed and characterized a CPP-based multi-epitopic cancer vaccine in the Laboratory of Tumour Immunology of the University of Geneva, which is the basis of the KISIMA proprietary vaccine platform. Madiha excitingly drove the integration of AMAL Therapeutics into the Boehringer Ingelheim.
SMPA Conference 2023 has been made possible thanks to the generous support of: